Evaluasi Penggunaan Obat pada Pasien Diabetes Melitus dengan Komplikasi Stroke di RSUD Aji Muhammad Parikesit Tenggarong Tahun 2020
Evaluation of Drug Use in Diabetes Mellitus Patients with Stroke Complications at Aji Muhammad Parikesit Hospital Tenggarong in 2020
DOI:
https://doi.org/10.25026/mpc.v15i1.633References
[1] Triplet, C.L., Reasner, C.A., dan Isley, W.L. 2005. Diabetes Mellitus, dalam Pharmacotherapy A PathoPhysiologic Approach, Sixth Edition, edited by J.T. Dipiro, McGraw-Hill Companie, Inc., 1333-1363.
[2] Wibowo, S., dan Gofir, A. 2001. Farmakoterapi dalam Neurologi, edisi 1. Jakarta: Salemba Medika, , 53-73.
[3] Robert, H. Eckel et al, 2002, Pathogenesis of Atherosclerosis in Diabetes, http://arc.ahajournals.org/cgi/content/full/105/18/e138.
[4] Gilroy, J. 2000. Basic Neurology 3rd ed. New York : McGraw-Hill.
[5] Hankey, G.J., Lees, K.R. 2001. Stroke Management in Practice. London: Mosby International Limited.
[6] Kusumawati, I. 2015. Kepatuhan Menjalani Diet ditinjau dari Jenis Kelamin dan Tingkat Pendidikan pada Penderita Diabetes Melitus Tipe 2. Jurnal Fakultas Psikologi.
[7] Gofil, Abdul. 2009. Manajemen STROKE. Yogyakarta: pustaka cendekia press.
[8] Handoko, T., dan Suharto B. 1995. Insulin Glukagon dan Antidiabetik Dalam Farmakologi dan Terapi, edisi IV, editor: Sulistia G. Ganiswara, Jakarta : Gaya Baru. Halaman 469, 471-472.
[9] Aronow, W.S., Fleg, J.L., Pepine, C.J., Artinian, N.T., Bakris, G., Brown, A.S., et al. 2011. ACCF/AHA 2011 Expert Consensus Document on Hypertension in The Elderly. Journal of American Society of Hypertension, 5(4):259-352.
[10] Gonya, G., Arrich, J., Wolzt, M., Huber, K., Verheugt, F.W., Gurbel, P.A., et al. 2014. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: A systematic review and meta-analysis, Stroke, 45:492-503.
[2] Wibowo, S., dan Gofir, A. 2001. Farmakoterapi dalam Neurologi, edisi 1. Jakarta: Salemba Medika, , 53-73.
[3] Robert, H. Eckel et al, 2002, Pathogenesis of Atherosclerosis in Diabetes, http://arc.ahajournals.org/cgi/content/full/105/18/e138.
[4] Gilroy, J. 2000. Basic Neurology 3rd ed. New York : McGraw-Hill.
[5] Hankey, G.J., Lees, K.R. 2001. Stroke Management in Practice. London: Mosby International Limited.
[6] Kusumawati, I. 2015. Kepatuhan Menjalani Diet ditinjau dari Jenis Kelamin dan Tingkat Pendidikan pada Penderita Diabetes Melitus Tipe 2. Jurnal Fakultas Psikologi.
[7] Gofil, Abdul. 2009. Manajemen STROKE. Yogyakarta: pustaka cendekia press.
[8] Handoko, T., dan Suharto B. 1995. Insulin Glukagon dan Antidiabetik Dalam Farmakologi dan Terapi, edisi IV, editor: Sulistia G. Ganiswara, Jakarta : Gaya Baru. Halaman 469, 471-472.
[9] Aronow, W.S., Fleg, J.L., Pepine, C.J., Artinian, N.T., Bakris, G., Brown, A.S., et al. 2011. ACCF/AHA 2011 Expert Consensus Document on Hypertension in The Elderly. Journal of American Society of Hypertension, 5(4):259-352.
[10] Gonya, G., Arrich, J., Wolzt, M., Huber, K., Verheugt, F.W., Gurbel, P.A., et al. 2014. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: A systematic review and meta-analysis, Stroke, 45:492-503.
Downloads
Published
2022-05-31
How to Cite
Nuraisyah, N., Ramadhan, A. M., & Sari, D. M. (2022). Evaluasi Penggunaan Obat pada Pasien Diabetes Melitus dengan Komplikasi Stroke di RSUD Aji Muhammad Parikesit Tenggarong Tahun 2020: Evaluation of Drug Use in Diabetes Mellitus Patients with Stroke Complications at Aji Muhammad Parikesit Hospital Tenggarong in 2020. Proceeding of Mulawarman Pharmaceuticals Conferences, 15(1), 142–148. https://doi.org/10.25026/mpc.v15i1.633
Issue
Section
Articles
License
Copyright (c) 2022 Proceeding of Mulawarman Pharmaceuticals Conferences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
